新闻
2024-03-21
肝癌一线疗法显著改善OS!百时美施贵宝3期试验积极结果公布
临床结果上市批准临床成功
2024-03-20
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer
临床结果快速通道ASCO会议
2024-03-20
AEON Biopharma Announces Clinical Update and Productive End-of-Phase 2 Meeting with FDA on ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Migraine
临床研究临床3期
2024-03-20
临床3期ASH会议
2024-03-20
US FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) – the first and only endothelin receptor antagonist for the treatment of high blood pressure not adequately controlled in combination with other antihypertensives
临床结果上市批准AHA会议
2024-03-20
Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
临床2期临床结果
2024-03-20
治疗MASH/NASH和2型糖尿病,创新药物达2期试验主要终点
突破性疗法基因疗法临床结果ASH会议
2024-03-20
特瑞思TRS005拟纳入突破性治疗品种
抗体药物偶联物突破性疗法IPO
2024-03-20
治疗胃癌,华昊中天「优替德隆口服胶囊」获FDA孤儿药资格!
孤儿药IPO疫苗
2024-03-20
Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects
临床1期临床2期